This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.

Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.

4cgm

From Proteopedia

(Difference between revisions)

Jump to: navigation, search

Revision as of 17:45, 7 September 2022

Leishmania major N-myristoyltransferase in complex with a biphenyl- derivative inhibitor

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "http://52.214.119.220/wiki/index.php/4cgm"

@@ Line 3: / Line 3: @@
 <StructureSection load='4cgm' size='340' side='right'caption='[[4cgm]], [[Resolution|resolution]] 1.70&Aring;' scene=''>
 == Structural highlights ==
-<table><tr><td colspan='2'>[[4cgm]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Leima Leima]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4CGM OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4CGM FirstGlance]. <br>
+<table><tr><td colspan='2'>[[4cgm]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Leishmania_major Leishmania major]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4CGM OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4CGM FirstGlance]. <br>
-</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=CWZ:N-[[3-[3-(6,7-DIHYDRO-4H-[1,3]THIAZOLO[5,4-C]PYRIDIN-5-YLMETHYL)PHENYL]PHENYL]METHYL]-2-PYRIDIN-3-YL-ETHANAMINE'>CWZ</scene>, <scene name='pdbligand=MG:MAGNESIUM+ION'>MG</scene>, <scene name='pdbligand=MYA:TETRADECANOYL-COA'>MYA</scene></td></tr>
+</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=CWZ:N-[[3-[3-(6,7-DIHYDRO-4H-[1,3]THIAZOLO[5,4-C]PYRIDIN-5-YLMETHYL)PHENYL]PHENYL]METHYL]-2-PYRIDIN-3-YL-ETHANAMINE'>CWZ</scene>, <scene name='pdbligand=MG:MAGNESIUM+ION'>MG</scene>, <scene name='pdbligand=MYA:TETRADECANOYL-COA'>MYA</scene></td></tr>
-<tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[4cgl|4cgl]], [[4cgn|4cgn]], [[4cgo|4cgo]], [[4cgp|4cgp]]</td></tr>
+<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4cgm FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4cgm OCA], [https://pdbe.org/4cgm PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4cgm RCSB], [https://www.ebi.ac.uk/pdbsum/4cgm PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4cgm ProSAT]</span></td></tr>
-<tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Glycylpeptide_N-tetradecanoyltransferase Glycylpeptide N-tetradecanoyltransferase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.3.1.97 2.3.1.97] </span></td></tr>
-<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4cgm FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4cgm OCA], [http://pdbe.org/4cgm PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=4cgm RCSB], [http://www.ebi.ac.uk/pdbsum/4cgm PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=4cgm ProSAT]</span></td></tr>
 </table>
 == Function ==
-[[http://www.uniprot.org/uniprot/Q4Q5S8_LEIMA Q4Q5S8_LEIMA]] Adds a myristoyl group to the N-terminal glycine residue of certain cellular proteins (By similarity).
+[[https://www.uniprot.org/uniprot/Q4Q5S8_LEIMA Q4Q5S8_LEIMA]] Adds a myristoyl group to the N-terminal glycine residue of certain cellular proteins (By similarity).
-<div style="background-color:#fffaf0;">
-== Publication Abstract from PubMed ==
-The leishmaniases are a spectrum of global diseases of poverty associated with immune dysfunction and are the cause of high morbidity. Despite the long history of these diseases, no effective vaccine is available and the currently used drugs are variously compromised by moderate efficacy, complex side effects and the emergence of resistance. It is therefore widely accepted that new therapies are needed. N-Myristoyltransferase (NMT) has been validated pre-clinically as a target for the treatment of fungal and parasitic infections. In a previously reported high-throughput screening program, a number of hit compounds with activity against NMT from Leishmania donovani have been identified. Here, high-resolution crystal structures of representative compounds from four hit series in ternary complexes with myristoyl-CoA and NMT from the closely related L. major are reported. The structures reveal that the inhibitors associate with the peptide-binding groove at a site adjacent to the bound myristoyl-CoA and the catalytic alpha-carboxylate of Leu421. Each inhibitor makes extensive apolar contacts as well as a small number of polar contacts with the protein. Remarkably, the compounds exploit different features of the peptide-binding groove and collectively occupy a substantial volume of this pocket, suggesting that there is potential for the design of chimaeric inhibitors with significantly enhanced binding. Despite the high conservation of the active sites of the parasite and human NMTs, the inhibitors act selectively over the host enzyme. The role of conformational flexibility in the side chain of Tyr217 in conferring selectivity is discussed.
-Diverse modes of binding in structures of Leishmania major N-myristoyltransferase with selective inhibitors.,Brannigan JA, Roberts SM, Bell AS, Hutton JA, Hodgkinson MR, Tate EW, Leatherbarrow RJ, Smith DF, Wilkinson AJ IUCrJ. 2014 Jun 17;1(Pt 4):250-60. doi: 10.1107/S2052252514013001. eCollection, 2014 Jul 1. PMID:25075346<ref>PMID:25075346</ref>
-From MEDLINE&reg;/PubMed&reg;, a database of the U.S. National Library of Medicine.<br>
-</div>
-<div class="pdbe-citations 4cgm" style="background-color:#fffaf0;"></div>
-== References ==
-<references/>
 __TOC__
 </StructureSection>
-[[Category: Glycylpeptide N-tetradecanoyltransferase]]
 [[Category: Large Structures]]
-[[Category: Leima]]
+[[Category: Leishmania major]]
-[[Category: Bell, A S]]
+[[Category: Bell AS]]
-[[Category: Brannigan, J A]]
+[[Category: Brannigan JA]]
-[[Category: Hutton, J A]]
+[[Category: Hutton JA]]
-[[Category: Leatherbarrow, R J]]
+[[Category: Leatherbarrow RJ]]
-[[Category: Roberts, S M]]
+[[Category: Roberts SM]]
-[[Category: Smith, D F]]
+[[Category: Smith DF]]
-[[Category: Tate, E W]]
+[[Category: Tate EW]]
-[[Category: Wilkinson, A J]]
+[[Category: Wilkinson AJ]]
-[[Category: Myristoylation]]
-[[Category: Transferase]]

4cgm

From Proteopedia

Revision as of 17:45, 7 September 2022

Leishmania major N-myristoyltransferase in complex with a biphenyl- derivative inhibitor

Structural highlights

Function

Contents

Proteopedia Page Contributors and Editors (what is this?)

Views

Personal tools

Navigation

Search

Toolbox